Table of Contents Executive Summary 1 Industry Overview of Becker Muscular Dystrophy Drug 1.1 Definition of Becker Muscular Dystrophy Drug 1.2 Becker Muscular Dystrophy Drug Segment by Type 1.2.1 Global Becker Muscular Dystrophy Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Givinostat 1.2.3 Ataluren 1.2.4 Epicatechin 1.2.5 ARM-210 1.2.6 Others 1.3 Becker Muscular Dystrophy Drug Segment by Applications 1.3.1 Global Becker Muscular Dystrophy Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Global Becker Muscular Dystrophy Drug Overall Market 1.4.1 Global Becker Muscular Dystrophy Drug Revenue (2014-2025) 1.4.2 Global Becker Muscular Dystrophy Drug Production (2014-2025) 1.4.3 North America Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 1.4.4 Europe Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 1.4.5 China Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 1.4.6 Japan Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 1.4.8 India Becker Muscular Dystrophy Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Becker Muscular Dystrophy Drug 2.3 Manufacturing Process Analysis of Becker Muscular Dystrophy Drug 2.4 Industry Chain Structure of Becker Muscular Dystrophy Drug 3 Development and Manufacturing Plants Analysis of Becker Muscular Dystrophy Drug 3.1 Capacity and Commercial Production Date 3.2 Global Becker Muscular Dystrophy Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Becker Muscular Dystrophy Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Becker Muscular Dystrophy Drug Production and Capacity Analysis 4.2 Becker Muscular Dystrophy Drug Revenue Analysis 4.3 Becker Muscular Dystrophy Drug Price Analysis 4.4 Market Concentration Degree 5 Becker Muscular Dystrophy Drug Regional Market Analysis 5.1 Becker Muscular Dystrophy Drug Production by Regions 5.1.1 Global Becker Muscular Dystrophy Drug Production by Regions 5.1.2 Global Becker Muscular Dystrophy Drug Revenue by Regions 5.2 Becker Muscular Dystrophy Drug Consumption by Regions 5.3 North America Becker Muscular Dystrophy Drug Market Analysis 5.3.1 North America Becker Muscular Dystrophy Drug Production 5.3.2 North America Becker Muscular Dystrophy Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Becker Muscular Dystrophy Drug Import and Export 5.4 Europe Becker Muscular Dystrophy Drug Market Analysis 5.4.1 Europe Becker Muscular Dystrophy Drug Production 5.4.2 Europe Becker Muscular Dystrophy Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Becker Muscular Dystrophy Drug Import and Export 5.5 China Becker Muscular Dystrophy Drug Market Analysis 5.5.1 China Becker Muscular Dystrophy Drug Production 5.5.2 China Becker Muscular Dystrophy Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Becker Muscular Dystrophy Drug Import and Export 5.6 Japan Becker Muscular Dystrophy Drug Market Analysis 5.6.1 Japan Becker Muscular Dystrophy Drug Production 5.6.2 Japan Becker Muscular Dystrophy Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Becker Muscular Dystrophy Drug Import and Export 5.7 Southeast Asia Becker Muscular Dystrophy Drug Market Analysis 5.7.1 Southeast Asia Becker Muscular Dystrophy Drug Production 5.7.2 Southeast Asia Becker Muscular Dystrophy Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Becker Muscular Dystrophy Drug Import and Export 5.8 India Becker Muscular Dystrophy Drug Market Analysis 5.8.1 India Becker Muscular Dystrophy Drug Production 5.8.2 India Becker Muscular Dystrophy Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Becker Muscular Dystrophy Drug Import and Export 6 Becker Muscular Dystrophy Drug Segment Market Analysis (by Type) 6.1 Global Becker Muscular Dystrophy Drug Production by Type 6.2 Global Becker Muscular Dystrophy Drug Revenue by Type 6.3 Becker Muscular Dystrophy Drug Price by Type 7 Becker Muscular Dystrophy Drug Segment Market Analysis (by Application) 7.1 Global Becker Muscular Dystrophy Drug Consumption by Application 7.2 Global Becker Muscular Dystrophy Drug Consumption Market Share by Application (2014-2019) 8 Becker Muscular Dystrophy Drug Major Manufacturers Analysis 8.1 Italfarmaco SpA 8.1.1 Italfarmaco SpA Becker Muscular Dystrophy Drug Production Sites and Area Served 8.1.2 Italfarmaco SpA Product Introduction, Application and Specification 8.1.3 Italfarmaco SpA Becker Muscular Dystrophy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Milo Biotechnology LLC 8.2.1 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production Sites and Area Served 8.2.2 Milo Biotechnology LLC Product Introduction, Application and Specification 8.2.3 Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 PTC Therapeutics Inc 8.3.1 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production Sites and Area Served 8.3.2 PTC Therapeutics Inc Product Introduction, Application and Specification 8.3.3 PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 ReveraGen BioPharma Inc 8.4.1 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production Sites and Area Served 8.4.2 ReveraGen BioPharma Inc Product Introduction, Application and Specification 8.4.3 ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Sarepta Therapeutics Inc 8.5.1 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production Sites and Area Served 8.5.2 Sarepta Therapeutics Inc Product Introduction, Application and Specification 8.5.3 Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 9 Development Trend of Analysis of Becker Muscular Dystrophy Drug Market 9.1 Global Becker Muscular Dystrophy Drug Market Trend Analysis 9.1.1 Global Becker Muscular Dystrophy Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Becker Muscular Dystrophy Drug Regional Market Trend 9.2.1 North America Becker Muscular Dystrophy Drug Forecast 2019-2025 9.2.2 Europe Becker Muscular Dystrophy Drug Forecast 2019-2025 9.2.3 China Becker Muscular Dystrophy Drug Forecast 2019-2025 9.2.4 Japan Becker Muscular Dystrophy Drug Forecast 2019-2025 9.2.5 Southeast Asia Becker Muscular Dystrophy Drug Forecast 2019-2025 9.2.6 India Becker Muscular Dystrophy Drug Forecast 2019-2025 9.3 Becker Muscular Dystrophy Drug Market Trend (Product Type) 9.4 Becker Muscular Dystrophy Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Becker Muscular Dystrophy Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Becker Muscular Dystrophy Drug Table Global Becker Muscular Dystrophy Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Becker Muscular Dystrophy Drug Production Market Share by Types in 2018 Figure Givinostat Product Picture Figure Ataluren Product Picture Figure Epicatechin Product Picture Figure ARM-210 Product Picture Figure Others Product Picture Table Global Becker Muscular Dystrophy Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Becker Muscular Dystrophy Drug Consumption Market Share by Applications in 2018 Figure Hospital Figure Clinic Figure Others Figure Global Becker Muscular Dystrophy Drug Revenue (Million USD) (2014-2025) Figure Global Becker Muscular Dystrophy Drug Production (K Pcs) (2014-2025) Figure North America Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Figure Europe Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Figure China Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Figure Japan Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Figure India Becker Muscular Dystrophy Drug Market Size (Million USD) (2014-2025) Table Becker Muscular Dystrophy Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Becker Muscular Dystrophy Drug in 2018 Figure Manufacturing Process Analysis of Becker Muscular Dystrophy Drug Figure Industry Chain Structure of Becker Muscular Dystrophy Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Becker Muscular Dystrophy Drug Manufacturing Plants Distribution Table Becker Muscular Dystrophy Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Becker Muscular Dystrophy Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Becker Muscular Dystrophy Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Becker Muscular Dystrophy Drug Production Market Share of Major Manufacturers (2014-2019) Figure Becker Muscular Dystrophy Drug Production Share by Manufacturers in 2018 Table Becker Muscular Dystrophy Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Becker Muscular Dystrophy Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Becker Muscular Dystrophy Drug Revenue Share by Manufacturers in 2018 Table Becker Muscular Dystrophy Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Becker Muscular Dystrophy Drug Production by Regions 2014-2019 (K Pcs) Table Global Becker Muscular Dystrophy Drug Production Market Share by Regions 2014-2019 Figure Global Becker Muscular Dystrophy Drug Production Market Share by Regions in 2018 Table Global Becker Muscular Dystrophy Drug Revenue by Regions 2014-2019 (Million USD) Table Global Becker Muscular Dystrophy Drug Revenue Market Share by Regions 2014-2019 Figure Global Becker Muscular Dystrophy Drug Revenue Market Share by Regions in 2018 Table Global Becker Muscular Dystrophy Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Becker Muscular Dystrophy Drug Consumption Market Share by Regions 2014-2019 Figure North America Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure Europe Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure China Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure Japan Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure India Becker Muscular Dystrophy Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Becker Muscular Dystrophy Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Becker Muscular Dystrophy Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Becker Muscular Dystrophy Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Becker Muscular Dystrophy Drug Market Share by Application (2014-2019) Table Italfarmaco SpA Becker Muscular Dystrophy Drug Production Sites and Area Served Table Italfarmaco SpA Becker Muscular Dystrophy Drug Product Introduction, Application and Specification Table Italfarmaco SpA Becker Muscular Dystrophy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Italfarmaco SpA Becker Muscular Dystrophy Drug Production Growth Rate (2014-2019) Table Italfarmaco SpA Becker Muscular Dystrophy Drug Production Market Share (2014-2019) Figure Italfarmaco SpA Becker Muscular Dystrophy Drug Revenue Market Share (2014-2019) Table Italfarmaco SpA Becker Muscular Dystrophy Drug Main Business and Markets Served Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production Sites and Area Served Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Product Introduction, Application and Specification Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production Growth Rate (2014-2019) Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Production Market Share (2014-2019) Figure Milo Biotechnology LLC Becker Muscular Dystrophy Drug Revenue Market Share (2014-2019) Table Milo Biotechnology LLC Becker Muscular Dystrophy Drug Main Business and Markets Served Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production Sites and Area Served Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Product Introduction, Application and Specification Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production Growth Rate (2014-2019) Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Production Market Share (2014-2019) Figure PTC Therapeutics Inc Becker Muscular Dystrophy Drug Revenue Market Share (2014-2019) Table PTC Therapeutics Inc Becker Muscular Dystrophy Drug Main Business and Markets Served Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production Sites and Area Served Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Product Introduction, Application and Specification Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production Growth Rate (2014-2019) Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Production Market Share (2014-2019) Figure ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Revenue Market Share (2014-2019) Table ReveraGen BioPharma Inc Becker Muscular Dystrophy Drug Main Business and Markets Served Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production Sites and Area Served Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Product Introduction, Application and Specification Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production Growth Rate (2014-2019) Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Production Market Share (2014-2019) Figure Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Revenue Market Share (2014-2019) Table Sarepta Therapeutics Inc Becker Muscular Dystrophy Drug Main Business and Markets Served Figure Global Becker Muscular Dystrophy Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Becker Muscular Dystrophy Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Becker Muscular Dystrophy Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Becker Muscular Dystrophy Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Becker Muscular Dystrophy Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Becker Muscular Dystrophy Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Becker Muscular Dystrophy Drug by Application (2019-2025) Table Becker Muscular Dystrophy Drug Distributors List Table Becker Muscular Dystrophy Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Italfarmaco SpA Milo Biotechnology LLC PTC Therapeutics Inc ReveraGen BioPharma Inc Sarepta Therapeutics Inc